Table Of Contents:
- Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
- Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
- Chapter 3. Vitrectomy Devices Market: By Product Type
- Vitrectomy Machines Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Vitrectomy Machines Definitions, Technology Landscape
- Vitrectomy Machines Market Drivers
- Product Launches
- Technology Launches
- Vitrectomy Machines Market Restraints
- Chapter 4. Vitrectomy Devices Market: By Application
- Diabetic Retinopathy Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Diabetic Retinopathy Definitions, Technology Landscape
- Diabetic Retinopathy Market Drivers
- Product Launches
- Technology Launches
- Diabetic Retinopathy Market Restraints
- Chapter 5. Vitrectomy Devices Market: By End-User
- Hospitals Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Hospitals Definitions, Technology Landscape
- Hospitals Market Drivers
- Product Launches
- Technology Launches
- Hospitals Market Restraints
- Chapter 6. Vitrectomy Devices Market: By Surgery Type
- 20G Vitrectomy Market Size (US$), CAGR (%), and Forecast (2021-2031)
- 20G Vitrectomy Definitions, Technology Landscape
- 20G Vitrectomy Market Drivers
- Product Launches
- Technology Launches
- 20G Vitrectomy Market Restraints
- Chapter 7. Vitrectomy Devices Market: Regional Market Trends, Size, and Future Outlook
- North America Vitrectomy Devices Market Size (US$), CAGR (%), and Forecast (2021-2031)
- North America Definitions, Technology Landscape
- North America Market Drivers
- Product Launches
- Technology Launches
- North America Market Restraints
- Competitive Outlook
- Europe
- Asia Pacific
- Latin America
- Middle East, and Africa
- Chapter 8. Vitrectomy Devices Market: Competitive Landscape
- Alcon (Novartis AG)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bausch & Lomb (Bausch Health Companies Inc.)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Johnson & Johnson Vision (Johnson & Johnson)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- ZEISS International
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Optos (Nikon Corporation)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Alcon (Novartis AG)
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The current market size of the Vitrectomy Devices industry is US$ 1,516.8 million as of 2023.
The key factors driving the growth of the Vitrectomy Devices market include the increasing prevalence of eye diseases, advancements in diagnostic technologies, the growing geriatric population, rising healthcare expenditure, and the adoption of minimally invasive surgical procedures.
The key factors hampering the growth of the Vitrectomy Devices Market include the high cost of vitrectomy procedures, the lack of skilled ophthalmologists, reimbursement challenges, and complications associated with vitrectomy.
The leading component segment in the Vitrectomy Devices Market is the vitrectomy machines segment, which is expected to hold a significant market share due to the increasing adoption of advanced vitrectomy platforms that offer improved visualization and precision during surgical procedures.
The major players operating in the Vitrectomy Devices Market include Alcon, Bausch & Lomb, Johnson & Johnson Vision, ZEISS International, Optos, Topcon Corporation, Lumenis, Oertli Instrumente AG, Suzhou Kangjie Medical Inc., and MedOne Surgical, Inc., among others.
The Vitrectomy Devices Market is expected to grow at a CAGR of 6.7% from 2024 to 2031, reaching a market size of US$ 2,548.3 million by 2031.
The key drivers of the Vitrectomy Devices Market include the increasing prevalence of eye diseases, advancements in diagnostic technology, the growing geriatric population, rising healthcare expenditure, and the adoption of minimally invasive surgical procedures.